Categories: NewsRobotics

ReWalk Robotics Ltd. to Present at the Emerging Growth Conference on July 12

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , July 11, 2023 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) announced Larry Jasinski, Chief Executive Officer, will present virtually at the Emerging Growth Conference at 10:15 am EDT on Wednesday, July 12, 2023.

For investors who are interested in participating, please use the link below to register and receive any conference updates:

https://goto.webcasts.com/starthere.jsp?ei=1603282&tp_key=1cd1dcc46a&sti=rwlk 

For attendees who are unable to join the event live, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, An archived link to the presentation will be available on the Company’s website after the event.

About ReWalk Robotics Ltd.:

ReWalk Robotics Ltd. is a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions. ReWalk’s mission is to fundamentally change the quality of life for these individuals through the creation and development of market leading technologies. Founded in 2001, ReWalk has operations in the U.S., Israel, and Germany. For more information on the ReWalk systems, please visit rewalk.com.

ReWalk® and ReStore® are registered trademarks of ReWalk Robotics Ltd. in the United States and other jurisdictions.

ReWalk Investor Contact:
Michael Lawless
Chief Financial Officer
ReWalk Robotics Ltd.
E: investorrelations@rewalk.com
ReWalk Media Relations:
John Tomlin
E: media@rewalk.com

Staff

Recent Posts

Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs

Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB:…

54 minutes ago

Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome

Phase 2 clinical trial initiated to evaluate SEMA3A mAb as potential treatment for Alport syndromeMilestone…

2 hours ago

AI-Driven Personalized Nutrition and Wellness Solutions Market worth USD 17,867.16 MN by 2032 | Credence Research

LONDON, Dec. 4, 2025 /PRNewswire/ -- The global AI-Driven Personalized Nutrition and Wellness Solutions Market…

5 hours ago

Shinoda Dental Signs MOU with Global Milling Manufacturer, Expands CAD/CAM Portfolio with Leading Brands

With expanded access to brands like Planmeca, Roland, Dentsply Sirona, and Ivoclar, Shinoda Dental becomes…

5 hours ago

BLACK PASTORS UNITED FOR EDUCATION (BPUE) WINS THE 2025 GREGOR G. PETERSON PRIZE IN VENTURE PHILANTHROPY

HARRISBURG, Pa., Dec. 3, 2025 /PRNewswire/ -- Black Pastors United for Education (BPUE), a faith-based…

11 hours ago

Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures

Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic…

11 hours ago